For years, NMN has been sold as the premium upgrade to NR. The first human head-to-head trial of NMN, NR and nicotinamide now suggests the two pricey options performed comparably at raising blood NAD+, while nicotinamide did not. The twist: gut microbes appear to convert NR and NMN into nicotinic acid, a potent NAD+ booster in blood experiments. That raises awkward questions about price, niacin and your microbiome. Here's what the 65-person study did and didn't show, including its 14-day, open-label, Nestlé-funded limits.
This page is available in